Dr Bernadette A Lavery

GenesisCare
Consultant Clinical Oncologist

Dr Bernadette Lavery has 23 years of consultant oncologist experience in Oxford specialising is breast cancer. She has held multiple local and regional leadership roles in cancer throughout her career including an extended period as breast cancer lead in Oxford and Thames Valley. She has been integral to implementation of advanced RT techniques for breast cancer patients throughout her career. She also works for NHSE as Thames Valley Cancer Alliance Clinical Director.

dont miss

Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

We will describe the use of SGRT to optimise patient positioning for radiotherapy for breast cancer, demonstrating improved accuracy and reliability, increased speed of set-up and better patient experience. The contribution of this to enabling advanced radiotherapy practice for breast cancer is discussed.

EVEN MORE SEMINARS

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg): Speaking at the Oncology Convention

    Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg)
    Sandwell and West Birmingham Hospitals NHS Trust

    Chest Wall Perforator Flaps for Partial Breast Reconstruction

  • Dr Qamar Ghafoor: Speaking at the Oncology Convention

    Dr Qamar Ghafoor
    University Hospital Birmingham

    Stereotactive Radiotherapy Treatment for Primary Lung Cancers, and Oligometastasis to the Lungs.

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours